Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC and Exosome Therapy for Diabetic Erectile Dysfunction
NCT07480161Phase 3Recruiting
- Sponsor
- Ankara City Hospital
- Start
- Dec 2025
- Primary completion
- Dec 2027
- Modality
- Lipid-based Nanoparticles, Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of human umbilical cord mesenchymal stem cells and umbilical cord derived mesenchymal stem cells exosomes in erectile dysfunction (ED) (3 arms), sponsored by Ankara City Hospital. Primary endpoints: International Index of Erectile Function-5 at 12 months and Erectile Hardness Score at 12 months. Started Dec 2025; status: recruiting.
02
Drugs
human umbilical cord mesenchymal stem cellsumbilical cord derived mesenchymal stem cells exosomes
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT07480161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07480161.